Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

The regulatory landscape of osteogenic differentiation.

Håkelien AM, Bryne JC, Harstad KG, Lorenz S, Paulsen J, Sun J, Mikkelsen TS, Myklebost O, Meza-Zepeda LA.

Stem Cells. 2014 Oct;32(10):2780-93. doi: 10.1002/stem.1759.

2.

Epigenetic Signatures at the RUNX2-P1 and Sp7 Gene Promoters Control Osteogenic Lineage Commitment of Umbilical Cord-Derived Mesenchymal Stem Cells.

Sepulveda H, Aguilar R, Prieto CP, Bustos F, Aedo S, Lattus J, van Zundert B, Palma V, Montecino M.

J Cell Physiol. 2017 Sep;232(9):2519-2527. doi: 10.1002/jcp.25627. Epub 2017 Mar 28.

PMID:
27689934
3.

Histone deacetylase inhibitor trichostatin A promotes the osteogenic differentiation of rat adipose-derived stem cells by altering the epigenetic modifications on Runx2 promoter in a BMP signaling-dependent manner.

Hu X, Zhang X, Dai L, Zhu J, Jia Z, Wang W, Zhou C, Ao Y.

Stem Cells Dev. 2013 Jan 15;22(2):248-55. doi: 10.1089/scd.2012.0105. Epub 2012 Nov 2.

PMID:
22873791
4.

microRNA-320/RUNX2 axis regulates adipocytic differentiation of human mesenchymal (skeletal) stem cells.

Hamam D, Ali D, Vishnubalaji R, Hamam R, Al-Nbaheen M, Chen L, Kassem M, Aldahmash A, Alajez NM.

Cell Death Dis. 2014 Oct 30;5:e1499. doi: 10.1038/cddis.2014.462.

5.

MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31.

Baglìo SR, Devescovi V, Granchi D, Baldini N.

Gene. 2013 Sep 15;527(1):321-31. doi: 10.1016/j.gene.2013.06.021. Epub 2013 Jul 1. Erratum in: Gene. 2014 Feb 10;535(2):380.

PMID:
23827457
6.

Osteogenic differentiation of C2C12 myogenic progenitor cells requires the Fos-related antigen Fra-1 - a novel target of Runx2.

Yu S, Geng Q, Sun F, Yu Y, Pan Q, Hong A.

Biochem Biophys Res Commun. 2013 Jan 4;430(1):173-8. doi: 10.1016/j.bbrc.2012.11.033. Epub 2012 Nov 15.

PMID:
23159633
7.

The effect of the cleidocranial dysplasia-related novel 1116_1119insC mutation in the RUNX2 gene on the biological function of mesenchymal cells.

Ding B, Li C, Xuan K, Liu N, Tang L, Liu Y, Guo W, Liu W, Jin Y.

Eur J Med Genet. 2013 Apr;56(4):180-7. doi: 10.1016/j.ejmg.2013.01.009. Epub 2013 Jan 31.

PMID:
23376464
8.

Heparin-binding EGF-like growth factor and miR-1192 exert opposite effect on Runx2-induced osteogenic differentiation.

Yu S, Geng Q, Ma J, Sun F, Yu Y, Pan Q, Hong A.

Cell Death Dis. 2013 Oct 17;4:e868. doi: 10.1038/cddis.2013.363.

9.

Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues.

Sanvoranart T, Supokawej A, Kheolamai P, U-Pratya Y, Klincumhom N, Manochantr S, Wattanapanitch M, Issaragrisil S.

Biochem Biophys Res Commun. 2014 May 16;447(4):580-5. doi: 10.1016/j.bbrc.2014.04.044. Epub 2014 Apr 18.

PMID:
24747566
10.

Conditioned medium from bone marrow mesenchymal stem cells transiently retards osteoblast differentiation by downregulating runx2.

Sun J, Zhou H, Deng Y, Zhang Y, Gu P, Ge S, Fan X.

Cells Tissues Organs. 2012;196(6):510-22. doi: 10.1159/000339245. Epub 2012 Aug 17.

11.

A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2.

Zhang Y, Xie RL, Croce CM, Stein JL, Lian JB, van Wijnen AJ, Stein GS.

Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9863-8. doi: 10.1073/pnas.1018493108. Epub 2011 May 31.

12.

MicroRNA-125b regulates osteogenic differentiation of mesenchymal stem cells by targeting Cbfβ in vitro.

Huang K, Fu J, Zhou W, Li W, Dong S, Yu S, Hu Z, Wang H, Xie Z.

Biochimie. 2014 Jul;102:47-55. doi: 10.1016/j.biochi.2014.02.005. Epub 2014 Feb 20.

PMID:
24560795
13.

Resveratrol mediated modulation of Sirt-1/Runx2 promotes osteogenic differentiation of mesenchymal stem cells: potential role of Runx2 deacetylation.

Shakibaei M, Shayan P, Busch F, Aldinger C, Buhrmann C, Lueders C, Mobasheri A.

PLoS One. 2012;7(4):e35712. doi: 10.1371/journal.pone.0035712. Epub 2012 Apr 23.

14.

Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue.

Deschaseaux F, Gaillard J, Langonné A, Chauveau C, Naji A, Bouacida A, Rosset P, Heymann D, De Pinieux G, Rouas-Freiss N, Sensébé L.

FASEB J. 2013 Aug;27(8):2977-87. doi: 10.1096/fj.13-227264. Epub 2013 Apr 16.

PMID:
23592762
15.

MAP Kinase-Dependent RUNX2 Phosphorylation Is Necessary for Epigenetic Modification of Chromatin During Osteoblast Differentiation.

Li Y, Ge C, Franceschi RT.

J Cell Physiol. 2017 Sep;232(9):2427-2435. doi: 10.1002/jcp.25517. Epub 2017 Apr 10.

16.

Role of ox-PAPCs in the differentiation of mesenchymal stem cells (MSCs) and Runx2 and PPARγ2 expression in MSCs-like of osteoporotic patients.

Valenti MT, Garbin U, Pasini A, Zanatta M, Stranieri C, Manfro S, Zucal C, Dalle Carbonare L.

PLoS One. 2011;6(6):e20363. doi: 10.1371/journal.pone.0020363. Epub 2011 Jun 3.

17.

Interleukin-6 induces the lineage commitment of bone marrow-derived mesenchymal multipotent cells through down-regulation of Sox2 by osteogenic transcription factors.

Yoon DS, Kim YH, Lee S, Lee KM, Park KH, Jang Y, Lee JW.

FASEB J. 2014 Jul;28(7):3273-86. doi: 10.1096/fj.13-248567. Epub 2014 Apr 9.

PMID:
24719354
18.

Noggin suppression decreases BMP-2-induced osteogenesis of human bone marrow-derived mesenchymal stem cells in vitro.

Chen C, Uludağ H, Wang Z, Jiang H.

J Cell Biochem. 2012 Dec;113(12):3672-80. doi: 10.1002/jcb.24240.

PMID:
22740073
19.

Dynamic and distinct histone modifications of osteogenic genes during osteogenic differentiation.

Zhang YX, Sun HL, Liang H, Li K, Fan QM, Zhao QH.

J Biochem. 2015 Dec;158(6):445-57. doi: 10.1093/jb/mvv059. Epub 2015 Jun 14.

PMID:
26078467
20.

Hypoxia inhibits osteogenesis in human mesenchymal stem cells through direct regulation of RUNX2 by TWIST.

Yang DC, Yang MH, Tsai CC, Huang TF, Chen YH, Hung SC.

PLoS One. 2011;6(9):e23965. doi: 10.1371/journal.pone.0023965. Epub 2011 Sep 9.

Supplemental Content

Support Center